中文名 | [4-(4-氨基苯氧基)(2-吡啶基)]-N-(甲基-D3)甲酰胺 |
---|---|
英文名 | [4-(4-Aminophenoxy)(2-pyridyl)]-N-(methyl-d3)carboxamide |
英文别名 | 4-(4-aminophenoxy)-N-(trideuteriomethyl)pyridine-2-carboxamide |
分子式 | C13H10D3N3O2 |
---|---|
分子量 | 246.28000 |
精确质量 | 246.12000 |
PSA | 77.24000 |
LogP | 2.78780 |
储存条件 | 2-8°C |
~89% 1189975-18-5 |
文献:SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD; Feng, Weidong; Gao, Xiaoyong; Dai, Xiaojun Patent: US2013/60043 A1, 2013 ; Location in patent: Paragraph 0129; 0130 ; |
~% 1189975-18-5 |
文献:SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD; Feng, Weidong; Gao, Xiaoyong; Dai, Xiaojun Patent: US2013/60043 A1, 2013 ; |
~% 1189975-18-5 |
文献:SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD; Feng, Weidong; Gao, Xiaoyong; Dai, Xiaojun Patent: US2013/60043 A1, 2013 ; |
~% 1189975-18-5 |
文献:SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD.; Feng, Weidong; Gao, Xiaoyong; Dai, Xiaojun Patent: US2013/35492 A1, 2013 ; |
~% 1189975-18-5 |
文献:SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD.; Xing, Lidong; Sheng, Zelin; Wu, Guozhang; Lu, Huiping Patent: US2013/12548 A1, 2013 ; |
~% 1189975-18-5 |
文献:SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD; Feng, Weidong; Gao, Xiaoyong; Dai, Xiaojun Patent: US2013/60043 A1, 2013 ; |
上游产品 7 | |
---|---|
下游产品 1 | |